Skip to main content
logo
Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
114.92
-0.78 (-0.67%)
At close: Sep 10, 2026, 4:00 PM EDT
114.71
-0.21 (-0.18%)
Pre-market: Sep 11, 2026, 6:33 AM EDT

Corcept Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
55.1899.65141.21106.14101.42112.51
Depreciation & Amortization
2.421.891.342.363.453.48
Loss (Gain) From Sale of Investments
-3.64-5.1-10.94-9.131.38-
Stock-Based Compensation
96.1184.561.3548.9442.4442.93
Other Operating Activities
-16.3-37.54-40.19-29.49-33.919.44
Change in Accounts Receivable
-12.35-5.81-12.85-10.07-3.43-1.43
Change in Inventory
-11-7.480.311.271.23.44
Change in Accounts Payable
-8.9725.07-2.025.424.76-3.6
Change in Income Taxes
1.091.093.781.218.690.01
Change in Other Net Operating Assets
7.15-14.2856.3210.03-5.671.1
Operating Cash Flow
109.7142198.3126.68120.32167.89
Operating Cash Flow Growth
-39.86%-28.39%56.53%5.28%-28.33%10.48%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.78-0.21-2.17-0.14-0.41-0.47
Investment in Securities
-19.1269.97-175.4391.05-113.91136.6
Investing Cash Flow
-21.969.76-177.690.91-114.33136.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
25.4725.499.625.814.3816.23
Repurchase of Common Stock
-104.37-245.86-37.97-154.53-21.67-318.82
Financing Cash Flow
-78.91-220.37-28.35-148.72-17.28-302.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.61.44-0.230.36--
Net Cash Flow
8.29-7.17-7.8969.22-11.291.43

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
106.92141.79196.12126.54119.91167.42
Free Cash Flow Growth
-40.76%-27.71%54.99%5.53%-28.38%11.07%
Free Cash Flow Margin
12.87%18.62%29.05%26.23%29.84%45.75%
Free Cash Flow Per Share
0.911.181.731.131.031.33
Levered Free Cash Flow
77.4114.19183.85128.39115.55120.18
Unlevered Free Cash Flow
77.4114.19183.85128.39115.55120.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
12.9712.9760.2747.639.759.1
Change in Working Capital
-24.07-1.4145.537.865.54-0.47
SEC Filings: 10-K · 10-Q